Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
Go back to Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH| (NASDAQ: MDGL) | Delayed: 543.35 +5.70 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $537.65 | 52 Week High | $18.24 | |||
| Open | $537.65 | 52 Week Low | $6.60 | |||
| Day High | $549.04 | P/E | N/A | |||
| Day Low | $526.61 | EPS | $0.00 | |||
| Volume | 160,513 | |||||
